InvestorsHub Logo

kyouter

11/11/14 10:07 AM

#10920 RE: specular #10919

Any mention on Rizaport (migraine)for the FDA issue?

Was hoping Redhill would at least touch on any development or update on the vendor issue. Seems like lost issue from both companies. Would not expect any different from igxt report. It does not look good.